COMPANY OVERVIEW Fixed income Facebook Twitter LinkedIn At a glance Net debt December 31, 2020: net debt of €8,790 million (gross debt of €22,631 million after derivatives minus €13,915 million cash and cash equivalents) Net debt is a non GAAP measure Gearing ratio: Debt, net of cash and cash equivalents, to total equity € MILLION 2020 2019 LONG-TERM DEBT 19,745 20,131 SHORT-TERM DEBT AND CURRENT PORTION OF LONG-TERM DEBT 2,767 4,554 INTEREST RATE AND CURRENCY DERIVATIVES USED TO HEDGE DEBT 119 (117) TOTAL DEBT 22,631 24,568 CASH AND CASH EQUIVALENTS (13,915) (9,427) INTEREST RATE AND CURRENCY DERIVATIVES USED TO MANAGE CASH AND CASH EQUIVALENTS 74 (34) NET DEBT* 8,790 15,107 TOTAL EQUITY 63,147 59,108 GEARING RATIO 13.9% 25.6% *With effect from January 1, 2019, the first-time application of IFRS 16 means that lease liabilities are not included in net debt. Credit ratings Credit ratings assess the credit worthiness of the Company and its ability to pay its debt. Sanofi is followed by three credit rating agencies: MOODY’S STANDARD & POOR’S SCOPE RATINGS ANALYST Marie Fischer-Sabatie Sabrina Boudella Olaf Tolke SHORT-TERM RATING P-1 A-1+ S-1+ LONG-TERM RATING A1 AA AA OUTLOOK Stable Stable Positive LAST UPDATE June 3, 2020 June 3, 2020 May 19, 2021 Debt structure Gross debt structure at value on redemption as of December 31, 2020 Financing instruments Public debt programs as of December 31, 2020 EMTN program: €25 billion Implemented in May 17, 2021 Base Prospectus - May 17, 2021 First supplement to the Base Prospectus - September 16, 2021 US SEC Shelf Registered program: no specific size Implemented in March 15, 2016 Negotiable European Commercial Papers (NEU CP): €6 billion Implemented on June 9, 2021 NEU CP Program - June 2021 U.S. Commercial Papers: $10 billion Implemented in December 22, 2004 Syndicated credit lines as of December 31, 2020 SIZE MATURITY €4 billion December 2021 €4 billion December 2025 Bonds as of December 31, 2020 Bonds Issued by Sanofi S.A ISSUANCE DATE AMOUNT OUTSTANDING (MILLION OF LOCAL CURRENCY) MATURITY COUPON ISIN MARCH 29, 2011 USD 2,000 March 29, 2021 4.000% US80105NAG07 NOV. 14, 2013 EUR 1,000 Nov. 14, 2023 2.500% FR0011625433 SEPT. 10, 2014 EUR 1,000 March 10, 2022 1.125% FR0012146777 SEPT. 10, 2014 EUR 1,510 Sept. 10, 2026 1.750% FR0012146801 SEPT. 22, 2015 EUR 500 Sept. 22, 2021 0.875% FR0012969020 SEPT. 22, 2015 EUR 750 Sept. 22, 2025 1.500% FR0012969038 APRIL 5, 2016 EUR 600 April 5, 2024 0.625% FR0013143997 APRIL 5, 2016 EUR 700 April 5, 2028 1.125% FR0013144003 SEPT. 13, 2016 EUR 850 Sept. 13, 2022 0.000% FR0013201621 SEPT. 13, 2016 EUR 1,150 Jan. 13, 2027 0.500% FR0013201639 MARCH 21, 2018 EUR 1750 March 21, 2023 0,500% FR0013324332 MARCH 21, 2018 EUR 1500 March 21, 2026 1,000% FR0013324340 MARCH 21, 2018 EUR 2000 March 21, 2030 1,375% FR0013324357 MARCH 21, 2018 EUR 1250 March 21, 2038 1,875% FR0013324373 JUNE 19, 2018 USD 1000 June 19, 2023 3,375% US801060AC87 JUNE 19, 2018 USD 1000 June 19, 2028 3,625% US801060AD60 MARCH 21, 2019 EUR 850 March 21, 2022 0.000% FR0013409836 MARCH 21, 2019 EUR 650 March 21, 2029 0.875% FR0013409844 MARCH 21, 2019 EUR 500 March 21, 2034 1.250% FR0013409851 MARCH 30, 2020 EUR 1000 April 1, 2030 1.500% FR0013505112 MARCH 30, 2020 EUR 1000 April 1, 2025 1.000% FR0013505104 Notes: Private placements are not included in this list Before derivative instruments Follow us Sanofi on Twitter Sanofi TV on YouTube Sanofi On LinkedIn Sanofi on Instagram Sanofi RSS feeds Contact Legal notice Privacy & Data Protection Cookies policy Corporate code of ethics Our publications Sitemap Our websites Accessibility: partial compliance © Sanofi 2004-2021 - All rights reserved